How Congressman Comer Brought CBD Products Into Congress
The quest to make CBD products legal is taking a new turn as congressman James Comer showcased CBD products during a congressional hearing. The Congressman from the Grand Old Party decided to bring two CBD containing products he has used for quite some time to discuss the differences between hemp and marijuana. To further buttress his point, Comer made it clear that millions of Americans now use cannabidiol or CBD, including congress members like himself; hence there is no reason not to legalize the products for medicinal use formally.
There is a lot of confusion and misinformation concerning the nature of THC and CBD. Most people still find it hard to differentiate between the two, even though they interact with the endocannabinoid system and its receptors in different ways.Throughout his presentation, Congressman Comer discussed the differences between cannabis and hemp by parallelizing it with cauliflower and broccoli. He made it clear that both come from the same family with many similarities and differences in interacting with the ECS receptors and body cells.
According to his presentation, most CBD products distributed in the US are extracted from hemp and not marijuana, thus making them possess more beneficial than harmful effects. It is pertinent to note that hemp contains more of CBD than THC, hence the reason it is mostly used in CBD products. THC is highly psychoactive and can tamper with brain activities, thus making the users high.
Comer went further to discuss his personal experience with CBD preparations. He said that the majority of the companies he had visited produced legitimate and good CBD products which contain more CBD than THC. In compliance with the laws guiding the production and manufacturing of CBD products, all products must contain less than 0.3% THC. As a former state agriculture commissioner before joining Congress, Comer is in a better position to enlighten the Congress about CBD products and the manufacturing process.
In response to the need for regulation, Comer supported the idea of formulating more regulations to guide the industry. He made it clear that there is a lack of regulations on the use of CBD oil from the Food and Drug Administration (FDA). Many of the legitimate and credible CBD companies are, however, pushing for more regulations that will allow them to distribute their products without many challenges. Congressman Comer concluded by making reference to the bipartisan letter they sent to the FDA on the need to allow the global marketing of CBD products.
If members of Congress are using CBD products, does this mean CBD will soon be more laxly regulated by the FDA? Only time will tell. In the meantime, some congressmen believe more regulations should be put in place on the use and distribution of CBD products.